2m 2m 2m 2m 2m 2m 2m
Assertio Hldgs (ASRT)
NASDAQ
$23.43-$0.04 (-0.17%)
Price as of Jun 03, 2026 7:55 PM EDT- $151.5MMarket Cap
- 133.30%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Assertio Hldgs (ASRT)
$23.43-$0.04 (-0.17%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 117.1M -6.29% | 125.0M -17.83% | 152.1M -2.67% | 156.2M +40.73% | |
Cost of Revenue | 35.4M -9.80% | 39.2M +45.18% | 27.0M +44.12% | 18.7M +18.42% | |
Gross Profit | 81.7M -4.69% | 85.7M -31.44% | 125.0M -9.05% | 137.5M +44.45% | |
Sales and Marketing Expense | 69.0M -8.06% | 75.1M -4.56% | 78.6M +68.08% | 46.8M -17.27% | |
Research and Development Expense | -1.7M -55.78% | -3.8M +34.44% | -2.8M N/A | N/A N/A | |
Depreciation and Amortization Expense | 30.0M +16.17% | 25.8M -8.50% | 28.2M -15.47% | 33.4M +14.85% | |
Total Operating Expenses | 140.2M -6.15% | 149.4M -62.23% | 395.6M +238.62% | 116.8M +15.00% | |
Operating Profit | -21.5M -12.01% | -24.5M -89.95% | -243.5M -718.03% | 39.4M +318.13% | |
Interest Income | 2.7M -17.26% | 3.2M N/A | N/A N/A | N/A N/A | |
Interest Expense | -3.1M +1.18% | -3.0M -10.09% | -3.4M -57.54% | -8.0M -22.10% | |
Interest Income and Expense and Net | -410,000 -325.27% | 182,000 +105.38% | -3.4M -57.54% | -8.0M -22.10% | |
Total Nonoperating Income and Expense | -8.4M -385.17% | 2.9M +128.02% | -10.5M +27.66% | -8.2M -17.42% | |
Income before Taxes | -29.9M +39.07% | -21.5M -91.53% | -254.1M -915.16% | 31.2M +5,735.80% | |
Income Taxes | 435,000 +736.54% | 52,000 -99.93% | 77.9M +199.27% | -78.5M -10,877.34% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -30.4M +40.75% | -21.6M -93.50% | -331.9M -402.80% | 109.6M +8,657.77% | |
Net Income from Continuing Operations Applicable to Common | -29.9M +39.07% | -21.5M -91.53% | -254.1M -915.16% | 31.2M +5,735.80% | |
Basic EPS and Net Income | -4.74 +1,960.87% | -0.23 -95.07% | -4.67 -300.43% | 2.33 +7,866.67% | |
Diluted EPS and Net Income | -4.74 +1,960.87% | -0.23 -95.07% | -4.67 -330.05% | 2.03 +6,866.67% | |
Basic Weighted Average Shares | 6.4M -93.28% | 95.3M +34.13% | 71.0M +51.12% | 47.0M +8.88% | |
Diluted Weighted Average Shares | 6.4M -93.28% | 95.3M +34.13% | 71.0M +29.93% | 54.7M +26.64% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 10.2M -79.78% | 50.6M -31.12% | 73.4M +13.09% | 64.9M +76.42% | |
Short-Term Investments | 53.2M +7.50% | 49.5M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 63.4M -36.63% | 100.1M +36.24% | 73.4M +13.09% | 64.9M +76.42% | |
Total Current Assets | 216.6M +6.96% | 202.5M +18.41% | 171.1M +29.34% | 132.3M +27.79% | |
Accumulated Depreciation | 3.5M +4.18% | 3.4M -26.65% | 4.6M +17.75% | 3.9M -66.52% | |
Property and Plant and Equipment and Net | 444,000 -24.23% | 586,000 -23.90% | 770,000 +3.49% | 744,000 -51.28% | |
Total Long-Term Assets | 972,000 -13.68% | 1.1M -65.41% | 3.3M +20.16% | 2.7M -50.46% | |
Total Assets | 267.0M -6.24% | 284.7M -0.59% | 286.4M -30.80% | 413.9M +26.75% | |
Income Taxes Payable | 594,000 -51.43% | 1.2M +17.82% | 1.0M N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 470,000 -96.14% | |
Total Current Liabilities | 127.5M +11.18% | 114.7M +22.74% | 93.4M -1.97% | 95.3M -29.41% | |
Total Long-Term Debt | 39.1M +0.80% | 38.8M +0.78% | 38.5M -42.00% | 66.4M +8.29% | |
Total Long-Term Liabilities | 6.4M -37.13% | 10.2M -38.33% | 16.5M +285.55% | 4.3M -7.92% | |
Total Liabilities | 173.0M +5.72% | 163.7M +10.27% | 148.4M -21.13% | 188.2M -16.04% | |
Retained Earnings | -703.5M +4.51% | -673.1M +3.31% | -651.5M +103.86% | -319.6M -25.54% | |
Total Stockholders Equity | 94.0M -22.41% | 121.1M -12.26% | 138.0M -38.86% | 225.7M +120.40% | |
Total Shares Outstanding | 6.4M -93.28% | 95.5M +0.92% | 94.7M +95.92% | 48.3M +8.24% | |
Cash Flow | |||||
Cash from Operating Activities | -28.2M -206.72% | 26.4M -46.76% | 49.6M -36.89% | 78.6M +1,323.10% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 628,000 +129.20% | 274,000 +416.98% | |
Cash from Investing Activities | -12.0M -75.49% | -48.9M -1,679.30% | 3.1M +107.26% | -42.7M +130.35% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -189,000 -46.00% | -350,000 -99.21% | -44.2M +467.12% | -7.8M -126.85% | |
Financials Ratio | |||||
Gross Margin | 69.78% +1.71% | 68.61% -16.57% | 82.23% -6.55% | 88.00% +2.64% | |
Operating Margin | -18.39% -6.11% | -19.59% -87.77% | -160.15% -734.96% | 25.22% +197.11% | |
Return on Assets | -11.01% +45.71% | -7.56% -92.03% | -94.80% -420.15% | 29.61% +7,378.76% | |
Return on Equity | -28.25% +69.58% | -16.66% -90.87% | -182.52% -373.17% | 66.82% +4,218.61% | |
Revenue Growth | -6.29% -64.71% | -17.83% +568.67% | -2.67% -106.54% | 40.73% +813.47% | |
Current Ratio | 1.70 -3.80% | 1.77 -3.53% | 1.83 +31.93% | 1.39 +81.03% | |
Cash Ratio | 0.08 -81.82% | 0.44 -43.87% | 0.79 +15.35% | 0.68 +149.93% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.28 -5.80% | 0.30 -58.71% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.13 -16.77% | 0.16 -28.21% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow